The application of adenylate kinase to inhibition of aggregation and to disaggregation of blood platelets. The adenylate kinase is from Bacilus stearothermophilus. The adenylate kinase is a component of medication regulating blood platelets aggregation in blood vessels and supporting the treatment of myocardial infarction, brain stroke and venous thrombosis. The adenylate kinase can also be used in prevention of myocardial infarction, brain stroke and venous thrombosis.
展开▼